新型抗糖尿病药物格列齐特对血小板释放反应的影响及腺苷酸环化酶的作用 - Suppr | 超能文献

Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase.

作者信息

Lagarde M, Dechavanne M, Thouverez J P, Verry M

出版信息

Thromb Res. 1975 Apr;6(4):345-55. doi: 10.1016/0049-3848(75)90084-5.

DOI:10.1016/0049-3848(75)90084-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase.新型抗糖尿病药物格列齐特对血小板释放反应的影响及腺苷酸环化酶的作用

Thromb Res. 1975 Apr;6(4):345-55. doi: 10.1016/0049-3848(75)90084-5.

2

Cyclic 3',5'-adenosine monophosphate in human blood platelets. 3. The role of cyclic AMP in platelet aggregation.人血小板中的环3',5'-腺苷单磷酸。3. 环磷酸腺苷在血小板聚集中的作用。

Ser Haematol. 1970;3(4):100-13.

3

[Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].

Arzneimittelforschung. 1975 Mar;25(3):347-61.

4

[Aggregation inhibitors. The inhibition of platelet function by means of chemical substances].[聚集抑制剂。通过化学物质对血小板功能的抑制作用]

Thromb Diath Haemorrh Suppl. 1973;55:221-40.

5

[Experimental studies on mechanism of inhibition of thrombocyte aggregation caused by sulfonyl ureas. 1. Problems and methods].

Arzneimittelforschung. 1975 Jan;25(1):38-46.

6

The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets.

Br J Haematol. 1973 Apr;24(4):409-18. doi: 10.1111/j.1365-2141.1973.tb01667.x.

7

In vitro evaluation of inhibitors of platelet release and aggregation.血小板释放与聚集抑制剂的体外评估

Arch Surg. 1975 Aug;110(8):980-3. doi: 10.1001/archsurg.1975.01360140124024.

8

Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.环核苷酸与血小板聚集。聚集剂对环核苷酸代谢酶活性的影响。

Biochim Biophys Acta. 1976 Sep 24;444(2):579-95. doi: 10.1016/0304-4165(76)90402-5.

9

Sensitive determination for adenylate cyclase activity by cyclic adenosine 3',5'-monophosphate protein binding assay.通过环磷酸腺苷蛋白结合测定法灵敏测定腺苷酸环化酶活性

Naunyn Schmiedebergs Arch Pharmacol. 1974;286(1):83-96. doi: 10.1007/BF00499106.

10

The influence of benzamidine derivatives on human platelet function.

Thromb Diath Haemorrh. 1974 Mar 15;31(1):172-8.

引用本文的文献

1

Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).非胰岛素依赖型糖尿病（NIDDM）并发症的预防

Drugs. 1995 Aug;50(2):263-88. doi: 10.2165/00003495-199550020-00006.

2

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.磺酰脲类降糖药的临床药理学：第2部分。

Drugs. 1981 Oct;22(4):295-320. doi: 10.2165/00003495-198122040-00003.

3

Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.磺脲类药物的心血管不良反应。临床意义。

Med Toxicol. 1987 May-Jun;2(3):190-209. doi: 10.1007/BF03259864.